Navigation Links
Quintiles Appoints John Goodacre as General Counsel

RESEARCH TRIANGLE PARK, N.C., Dec. 11 /PRNewswire/ -- Quintiles Transnational Corp. today announced the appointment of John Goodacre as Executive Vice President and General Counsel.

Previously Senior Vice President, Global Risk Management and Quality Assurance, Goodacre joined Quintiles in 1998 as Vice President, European Legal Affairs.

"John has a thorough understanding of Quintiles and the clinical research industry, having served the company in various capacities over the past 20 years - including as outside counsel when we formed Quintiles (UK) Limited, our first international subsidiary, in 1987," said Dennis Gillings, CBE, Chairman and Chief Executive Officer of Quintiles Transnational. "With his strong legal background and experience in leading our risk management and QA group, John will help Quintiles continue to grow and protect our interests."

In his new role, Goodacre is responsible for Quintiles' global legal function and risk management; he also joins the Quintiles Transnational Executive Committee. He reports to Mike Mortimer, Executive Vice President and Chief Administrative Officer.

Prior to joining Quintiles, Goodacre spent more than 20 years practicing law as a partner in law firms in central London. He holds two degrees from Cambridge University.

About Quintiles

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the pharmaceutical, biotechnology and healthcare industries. With about 20,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at

SOURCE Quintiles Transnational Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Biomoda, Inc. and Quintiles Announce Agreement for Regulatory Consulting
2. Quintiles Acquires Central American Research Organization
3. WorldHeart Appoints David Pellone Chief Financial Officer
4. Novo Nordisk Appoints New Leader of North American Business
5. The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer
6. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
7. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
8. Resonant Medical Appoints New Vice President of Global Sales
9. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
10. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
11. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
Post Your Comments:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... On Saturday, ... a treadmill relay – Miles by Moonlight to raise money for the American Heart ... or more. , Teams will work together to keep their treadmills moving for ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... ... presenting the latest in wound care advancements to physician colleagues, skilled nursing facility ... is titled, "Navigating the Treacherous Waters of Wound Care." , "At many of ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
Breaking Medicine Technology: